Survey: Use of therapeutic drug monitoring for biologics in IBD

We are hoping to gain a better understanding of practice patterns with regards to the use of therapeutic drug monitoring (TDM) for infliximab and adalimumab in IBD. This short questionnaire is designed to investigate how widely TDM is used as well as how the results are interpreted. We would be very grateful if you would take 4-5 minutes of your time to complete it and all responses will be collected anonymously.